Kestra Private Wealth Services LLC Has $3.55 Million Position in Colgate-Palmolive (NYSE:CL)

Kestra Private Wealth Services LLC lowered its stake in shares of Colgate-Palmolive (NYSE:CL) by 3.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 39,070 shares of the company’s stock after selling 1,251 shares during the period. Kestra Private Wealth Services LLC’s holdings in Colgate-Palmolive were worth $3,552,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in CL. FMR LLC boosted its holdings in Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after purchasing an additional 2,674,807 shares in the last quarter. Barclays PLC boosted its holdings in Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. State Street Corp boosted its holdings in Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares in the last quarter. Nordea Investment Management AB boosted its holdings in Colgate-Palmolive by 32.5% during the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after purchasing an additional 1,247,731 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its holdings in Colgate-Palmolive by 864.1% during the third quarter. Jacobs Levy Equity Management Inc. now owns 777,854 shares of the company’s stock valued at $80,749,000 after purchasing an additional 697,168 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.9 %

CL opened at $85.94 on Tuesday. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. The company has a market cap of $70.21 billion, a price-to-earnings ratio of 24.41, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. The firm has a 50 day simple moving average of $90.36 and a 200 day simple moving average of $96.77. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the business earned $0.87 earnings per share. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.73 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.33%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is presently 56.82%.

Wall Street Analyst Weigh In

CL has been the subject of a number of research analyst reports. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. TD Cowen cut their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Barclays cut their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Stifel Nicolaus cut their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. Finally, JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.